Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.

Vogtländer NP, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD.

Vaccine. 2004 Jun 2;22(17-18):2199-201.

PMID:
15149777
2.

Immunogenicity and protective efficacy of influenza vaccination.

Hannoun C, Megas F, Piercy J.

Virus Res. 2004 Jul;103(1-2):133-8. Review. No abstract available.

PMID:
15163501
3.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
4.

Influenza vaccines.

Brede HD.

Int Arch Allergy Immunol. 1995 Dec;108(4):318-20. Review.

PMID:
7580301
5.

Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?

Skowronski DM, Tweed SA, De Serres G.

J Infect Dis. 2008 Feb 15;197(4):490-502. doi: 10.1086/524146. Review.

6.

Inactivated influenza virus vaccines in children.

Ruben FL.

Clin Infect Dis. 2004 Mar 1;38(5):678-88. Epub 2004 Feb 17. Review.

7.

[Possibilities for spring vaccination of schoolchildren against influenza].

Zykov MP.

Zh Mikrobiol Epidemiol Immunobiol. 1985 Aug;(8):95-101. Review. Russian. No abstract available.

PMID:
3904287
8.

Influenza vaccine 2008-2009.

[No authors listed]

Med Lett Drugs Ther. 2008 Oct 6;50(1296):77-9. Review.

PMID:
18833032
9.

Influenza immunization.

Glück R.

Biologicals. 1997 Jun;25(2):221-5. Review. No abstract available.

PMID:
9236056
10.

Intradermal vaccination to protect against yellow fever and influenza.

Roukens AH, Gelinck LB, Visser LG.

Curr Top Microbiol Immunol. 2012;351:159-79. doi: 10.1007/82_2011_124. Review.

PMID:
21416266
11.

Influenza and current guidelines for its control.

Gall SA.

Infect Dis Obstet Gynecol. 2001;9(4):193-5. Review. No abstract available.

12.

[New vaccines against influenza via inhalation].

Domínguez A, Vidal J.

Aten Primaria. 1999 Oct 15;24(6):313-5. Review. Spanish. No abstract available.

PMID:
10596220
13.

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

Zanetti AR, Amendola A, Besana S, Boschini A, Tanzi E.

Vaccine. 2002 Dec 20;20 Suppl 5:B29-32. Review.

PMID:
12477415
14.

Haemagglutination-inhibiting antibody to influenza virus.

de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD.

Dev Biol (Basel). 2003;115:63-73. Review.

PMID:
15088777
15.

[Indications for influenza vaccination in children with lung disorders. Dutch Association for Pediatric Medicine].

Neijens HJ, Rothbarth PH, Sprenger MJ.

Ned Tijdschr Geneeskd. 1997 Nov 15;141(46):2213-7. Review. Dutch.

PMID:
9550781
16.

[Testing of influenza virus vaccines--an international comparison].

Klett G, Stäber H, Willkommen H.

Z Gesamte Hyg. 1980;26(7):473-86. Review. German. No abstract available.

PMID:
7003931
17.

Correlates of vaccine protection from influenza and its complications.

McCullers JA, Huber VC.

Hum Vaccin Immunother. 2012 Jan;8(1):34-44. doi: 10.4161/hv.8.1.18214. Epub 2012 Jan 1. Review.

PMID:
22252001
18.

Immunological assessment of influenza vaccines and immune correlates of protection.

Reber A, Katz J.

Expert Rev Vaccines. 2013 May;12(5):519-36. doi: 10.1586/erv.13.35. Review.

PMID:
23659300
19.

Influenza vaccination and chemotherapy: a shot in the dark?

Ring A, Marx G, Steer C, Harper P.

Support Care Cancer. 2002 Sep;10(6):462-5. Epub 2002 Jan 31. Review.

PMID:
12353124
20.

Influenza DNA vaccine: an update.

Chen Z.

Chin Med J (Engl). 2004 Jan;117(1):125-32. Review. No abstract available.

PMID:
14733788
Items per page

Supplemental Content

Write to the Help Desk